Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-14

Clinical Trial Update: Effects of Roxithromycin on Quality of Life and Physiological Outcomes in Bronchiectasis [Phase 3]

View source ↗

Summary

Phase 3 trial updating on the effects of roxithromycin on quality of life and physiological outcomes in bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roxithromycin (Roxithromycin)

Snippet

Sponsor: Prince of Songkla University | Conditions: Quality of Life, Respiratory Function Tests | Phase 3 | Status: COMPLETED